BUZZ-Energy drink maker Celsius rises as Morgan Stanley turns bullish

Reuters
Oct 01, 2025
BUZZ-Energy drink maker Celsius rises as <a href="https://laohu8.com/S/MTK">Morgan Stanley</a> turns bullish

** Shares of Celsius Holdings CELH.O up 1% at $57.48 and rising for 3rd straight session on Tues after Morgan Stanley upgraded energy drink maker to 'overweight' from 'equal-weight'

** Brokerage boosted PT by $9 to $70, implying 23% upside to stock's last close

** Morgan Stanley analyst Eric Serotta said he sees another leg up in CELH's stock driven by a greater than expected reacceleration in revenue growth

** He pointed out that brand Celsius has returned to growth following last year's share slowdown, and he expects further improvement, with "much easier" comps from Dec through early Jun

** While Alani, which accounts for ~40% of CELH sales, Serotta says, growth has recently moderated in Q2, but added its trends remain "robust" ahead of the Dec 1, 2025 transition to the Pepsi system

** A month ago, PepsiCo PEP.O acquired 5% of CELH's preferred stock, increasing its total stake in co to about 11% after conversion

** Florida-based CELH bought peer Alani Nutrition in $1.8 bln deal completed in Apr

** Now, 18 of 23 analysts covering CELH rate stock "strong buy" or "buy", 4 rate "hold" and 1 recommends "sell"; median PT is $70, per LSEG

** With move on Tues, stock up ~118% YTD

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com ; 1-646-279-6380))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10